BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V105. A total of 1 filers reported holding BIOCEPT INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $5,000 | -54.5% | 15,608 | -5.1% | 0.00% | -55.6% |
Q4 2017 | $11,000 | -64.5% | 16,442 | -35.6% | 0.01% | -65.4% |
Q3 2017 | $31,000 | -11.4% | 25,546 | 0.0% | 0.03% | -13.3% |
Q2 2017 | $35,000 | -36.4% | 25,546 | -1.3% | 0.03% | -38.8% |
Q1 2017 | $55,000 | +175.0% | 25,880 | 0.0% | 0.05% | +172.2% |
Q4 2016 | $20,000 | -66.1% | 25,880 | -31.1% | 0.02% | -67.9% |
Q3 2016 | $59,000 | -21.3% | 37,549 | -66.7% | 0.06% | -24.3% |
Q2 2016 | $75,000 | -49.7% | 112,600 | -2.6% | 0.07% | -57.2% |
Q1 2016 | $149,000 | -6.9% | 115,600 | 0.0% | 0.17% | -3.4% |
Q4 2015 | $160,000 | -49.2% | 115,600 | -15.5% | 0.18% | -48.6% |
Q3 2015 | $315,000 | -9.7% | 136,800 | 0.0% | 0.35% | +2.1% |
Q2 2015 | $349,000 | +15.9% | 136,800 | +1.9% | 0.34% | +21.4% |
Q1 2015 | $301,000 | -9.6% | 134,300 | 0.0% | 0.28% | -7.0% |
Q4 2014 | $333,000 | -9.0% | 134,300 | -10.4% | 0.30% | -17.5% |
Q3 2014 | $366,000 | -60.3% | 149,900 | -2.3% | 0.37% | -57.4% |
Q2 2014 | $923,000 | -19.6% | 153,400 | -1.9% | 0.86% | -22.3% |
Q1 2014 | $1,148,000 | – | 156,400 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 115,600 | $149,000 | 0.17% |
Callan Capital, LLC | 37,736 | $49,000 | 0.02% |
Sterneck Capital Management, LLC | 11,750 | $15,000 | 0.01% |
Virtu KCG Holdings LLC | 26,353 | $34,000 | 0.00% |
Creative Planning | 56,340 | $73,000 | 0.00% |
MORGAN STANLEY | 5,112 | $7,000 | 0.00% |
BLAIR WILLIAM & CO/IL | 10,000 | $13,000 | 0.00% |
BlackRock Institutional Trust Company, N.A. | 170,198 | $220,000 | 0.00% |
MSI Financial Services Inc | 1,300 | $2,000 | 0.00% |
HighTower Advisors, LLC | 15,200 | $21,000 | 0.00% |